Key Laboratory of Laboratory Medical Diagnostics, Chinese Ministry of Education, Chongqing Medical University, #1 Yi-Xue-Yuan Road, 400016, Chongqing, Yu-zhong District, China.
Department of Cell Biology and Medical Genetics, Basic Medical School, Chongqing Medical University, #1 Yi-Xue-Yuan Road, 400016, Chongqing, Yu-zhong District, China.
Cell Death Dis. 2018 Jan 26;9(2):122. doi: 10.1038/s41419-017-0133-1.
Cancer-associated fibroblasts (CAFs) support tumorigenesis by stimulating cancer cell proliferation, and invasion, but how the premalignant stromal fibroblasts trigger epithelial changes remain unclear. We demonstrate that atypical ductal hyperplasia-associated fibroblasts (AHFs) are one kind of activated fibroblasts and stimulate cell growth and polarity change of epithelium-like tumor cell MCF-7 as CAFs-like fibroblasts. Microarray shows miR-200b and miR-200c are downregulated during AHFs and CAFs, and contribute to stromal fibroblast activity. Additionally, miR-200b/c with target gene IKKβ (inhibitor of nuclear factor kappa-B kinase β) control PAI-1 (plasminogen activator inhibitor-1) expression to regulate growth and polarity changes of MCF-7 cells through NF-κB pathway. Exploring the difference of AHFs in premalignant transformation is crucial for understanding the pathobiology of breast cancer progression.
癌相关成纤维细胞(CAFs)通过刺激癌细胞增殖和侵袭来支持肿瘤发生,但恶性前间质成纤维细胞如何引发上皮变化尚不清楚。我们证明,非典型导管增生相关成纤维细胞(AHFs)是一种激活的成纤维细胞,可刺激上皮样肿瘤细胞 MCF-7 的细胞生长和极性变化,类似于 CAFs 样成纤维细胞。微阵列显示 miR-200b 和 miR-200c 在 AHFs 和 CAFs 中下调,并有助于基质成纤维细胞的活性。此外,miR-200b/c 与靶基因 IKKβ(核因子 kappa-B 激酶 β 的抑制剂)一起控制 PAI-1(纤溶酶原激活物抑制剂-1)的表达,通过 NF-κB 途径调节 MCF-7 细胞的生长和极性变化。探索癌前转化中 AHFs 的差异对于理解乳腺癌进展的病理生物学至关重要。